Geode Capital Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Geode Capital Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-169,097	Closed	-$4.73M	–	4276
2019 Q3	$4.73M	Sell	169,097 -3,715	-2%	-$60.2K	﹤0.01%	2412
2019 Q2	$2.44M	Buy	172,812 +8,266	+5%	+$78.6K	﹤0.01%	2818
2019 Q1	$1.46M	Buy	164,546 +8,314	+5%	+$67.5K	﹤0.01%	3012
2018 Q4	$1.18M	Buy	156,232 +11,732	+8%	+$189K	﹤0.01%	3036
2018 Q3	$3.03M	Buy	144,500 +4,535	+3%	+$108K	﹤0.01%	2661
2018 Q2	$4.19M	Buy	139,965 +74,275	+113%	+$2.02M	﹤0.01%	2423
2018 Q1	$1.78M	Buy	65,690 +3,331	+5%	+$99.7K	﹤0.01%	2831
2017 Q4	$1.79M	Buy	62,359 +9,566	+18%	+$262K	﹤0.01%	2811
2017 Q3	$1.28M	Buy	+52,793	New	+$1.25M	﹤0.01%	3009

Geode Capital Management's DOVA Position: Q4 2019 in Review

Geode Capital Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 169,097 shares — an estimated $4.73M sold.

Geode Capital Management first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $4.73M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Geode Capital Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Geode Capital Management sold 169,097 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $4.73M.
Geode Capital Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Geode Capital Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $4.73M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.